For the management of dushivisha janya twak vikara manjisthadya agad will be given

â??CLINICAL EFFICACY OF MANJISTHYADYA AGAD IN DUSHIVISHA JANYA TWAK VIKARA W.S.R. TO ALLERGIC SKIN DISEASESâ??

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/12/048019

Enrollment

Registered

2022-12-12

Start date

Unknown

Completion date

Unknown

Last updated

2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L500- Allergic urticaria Health Condition 2: L500- Allergic urticaria

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient of age group between 18-70 years irrespective of sex, religion, socioeconomic status will be taken into consideration. 2. All the patients of Dushivisha janya allergic skin disorders, presenting symptoms like burning sensation, redness, itching will be included for clinical trial.

Exclusion criteria

Exclusion criteria: 1. Patients of burn, severe infective diseases, psoriasis, leprosy, measles, herpes, chicken pox, leucoderma, carcinoma, HIV, any terminal disorders. 2. Patients suffering from any severe or complicated systemic disease like diabetes, renal disease, liver disease, VDRL will be excluded from trial, pregnant woman, Lactating mother.

Design outcomes

Primary

Measure	Time frame
Reduction of symptoms of Dushivisha janya allergic skin disease 1) kandu 2) toda 3) daha 4) raag Timepoint: 15 days	—

Secondary

Measure	Time frame
Reduction of symptoms of Dushivisha janya tvak vikara 1) kandu 2) toda 3) daha 4) raag Timepoint: 45 days	—

Countries

India

Contacts

Public ContactDr Sangeeta Bhagat

Shri N.P.A.Govt.Ayurved College Raipur C.G.

sinchulkar@yahoo.co.in9425215318

Outcome results